PL376118A1 - Treatment of allergic conditions by use of il 21 - Google Patents

Treatment of allergic conditions by use of il 21

Info

Publication number
PL376118A1
PL376118A1 PL03376118A PL37611803A PL376118A1 PL 376118 A1 PL376118 A1 PL 376118A1 PL 03376118 A PL03376118 A PL 03376118A PL 37611803 A PL37611803 A PL 37611803A PL 376118 A1 PL376118 A1 PL 376118A1
Authority
PL
Poland
Prior art keywords
treatment
allergic conditions
allergic
conditions
Prior art date
Application number
PL03376118A
Other languages
English (en)
Polish (pl)
Inventor
John Roemer
Niels Peter Hundahl Moeller
Kresten Skak
Original Assignee
Novo Nordisk A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk A/S filed Critical Novo Nordisk A/S
Publication of PL376118A1 publication Critical patent/PL376118A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
PL03376118A 2002-10-11 2003-10-13 Treatment of allergic conditions by use of il 21 PL376118A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200201546 2002-10-11
DKPA200201587 2002-10-16
US41922502P 2002-10-17 2002-10-17

Publications (1)

Publication Number Publication Date
PL376118A1 true PL376118A1 (en) 2005-12-12

Family

ID=32096538

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03376118A PL376118A1 (en) 2002-10-11 2003-10-13 Treatment of allergic conditions by use of il 21

Country Status (8)

Country Link
EP (1) EP1553970A1 (de)
JP (1) JP2006525223A (de)
AU (1) AU2003273758A1 (de)
BR (1) BR0315134A (de)
CA (1) CA2501807A1 (de)
MX (1) MXPA05003729A (de)
PL (1) PL376118A1 (de)
WO (1) WO2004032953A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2334127T3 (es) 2002-12-13 2010-03-05 Zymogenetics, Inc. Produccion de il-21 en huespedes procariotas.
EP1753458A4 (de) * 2004-05-19 2009-07-22 Wyeth Corp Modulation der immunglobulinproduktion und atopische erkrankungen
ATE501278T1 (de) * 2005-09-22 2011-03-15 Inst Nat Sante Rech Med Verfahren zur verwendung von il-21

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999061617A1 (en) * 1998-05-29 1999-12-02 Human Genome Sciences, Inc. Interleukins-21 and 22
EP1165791B1 (de) * 1999-03-09 2007-10-31 ZymoGenetics, Inc. Humanes cytokin als ligand des zalpha rezeptors und dessen verwendungen
CA2416820A1 (en) * 2000-07-27 2002-02-07 Ludwig Institute For Cancer Research Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof
DK1432431T3 (en) * 2001-10-04 2017-07-10 Genetics Inst Llc Methods and compositions for modulating interleukin-21 activity
AU2003230834A1 (en) * 2002-04-09 2003-10-27 Beth Israel Deaconess Medical Center, Inc. Antagonists of il-21 and modulation of il-21-mediated t cell responses

Also Published As

Publication number Publication date
MXPA05003729A (es) 2005-06-17
EP1553970A1 (de) 2005-07-20
AU2003273758A1 (en) 2004-05-04
JP2006525223A (ja) 2006-11-09
CA2501807A1 (en) 2004-04-22
BR0315134A (pt) 2005-08-16
WO2004032953A1 (en) 2004-04-22

Similar Documents

Publication Publication Date Title
ZA200605950B (en) Treatment of ophthalmic conditions
IL175529A0 (en) Methods and compositions for the treatment of metabolic disorders
IL164266A0 (en) Treatment of gastroparesis
HK1074784A1 (en) Treatment of mucositis
ZA200410409B (en) Use of thio-oxindole derivatives in treatment of hormonerelated conditions
EP1505961A4 (de) Verfahren zur behandlung allergischer reaktionen
PL371281A1 (en) Methods and compositions for the treatment of eye diseases
GB0213869D0 (en) The treatment of pain
PL375564A1 (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma
GB0211295D0 (en) Treatment of pain
EP1575497A4 (de) Neue zusammensetzung und verfahren zur behandlung von psoriasis
EP1581209A4 (de) Neue benzopyran-analoga und ihre verwendung zur behandlung von glaukom
AU2003289652A1 (en) The use of compound helicid for manufacturing medicine to treat depresion and/or disorders caused by depresion
PL376118A1 (en) Treatment of allergic conditions by use of il 21
AP2004003174A0 (en) Treatment of water
EP1560592A4 (de) Behandlung von allergieleiden
GB0101146D0 (en) Treatment of skin conditions
GB0217493D0 (en) Novel methods of treatment
GB0221712D0 (en) Methods of treatment
AU2003240174A8 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
EP1546326A4 (de) Neue zusammensetzungen und verfahren zur behandlung von psoriasis
AU2003250329A8 (en) Regulation of novel human asparagine-hydroxylases
GB0127206D0 (en) Treatment of inflammatory conditions
AU2003252187A8 (en) Topical composition for the treatment of inflammatory conditions of the skin
GB0221248D0 (en) Treatment of basal ganglia-related movement disorders

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)